Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi

Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi

OBJECTIVE: To estimate the impact of cotrimoxazole prophylaxis on the survival of human immunodeficiency virus (HIV)-positive tuberculosis (TB) patients. METHODS: A cohort study with a historical comparison group was conducted. End-of-treatment outcomes and 18-month survival were compared between TB...

Full description

Bibliographic Details
Main Authors: Mwaungulu Frank B.D., Floyd Sian, Crampin Amelia C., Kasimba Simplex, Malema Simon, Kanyongoloka Huxley, Harries Anthony D., Glynn Judith R., Fine Paul E.M.
Format: Article
Language:English
Published: The World Health Organization 2004-01-01
Series:Bulletin of the World Health Organization
Subjects:
Trimethoprim-sulfamethoxazole combination/pharmacology
Tuberculosis/mortality
Tuberculosis/drug therapy
AIDS-related opportunistic infections/drug therapy
HIV infections
Treatment outcome
Survival analysis
Cohort studies
Malawi
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862004000500009

Internet

http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862004000500009

Similar Items